API site WHO GMP risk during prequalification preparation – evidence pack for WHO audits



Published on 29/01/2026

Managing WHO GMP Risks During API Site Prequalification Preparation

As pharmaceutical professionals navigate the regulatory landscape for prequalification, ensuring compliance with WHO GMP standards is a daunting but critical task. A variety of factors can impact the readiness of Active Pharmaceutical Ingredient (API) sites for WHO audits. This playbook will guide you in evaluating and addressing risks associated with WHO GMP compliance during prequalification preparation.

By the end of this article, you will have actionable strategies across various roles—Production, Quality Control (QC), Quality Assurance (QA), Engineering, and Regulatory Affairs (RA)—to effectively triage symptoms, investigate potential failures, implement controls, and maintain inspection-ready documentation.

Symptoms/Signals on the Floor or in the Lab

Recognizing early warning signs of potential WHO GMP compliance issues is paramount in prequalification preparation. Common symptoms include:

  • Document Variability: Frequent discrepancies in batch records or quality control documentation.
  • Production Delays: Unexpected downtimes or deviations leading to loss of production time.
  • Inconsistent Quality: Frequent Out-of-Specification (OOS) results or repeated deviations during routine testing.
  • Equipment Malfunctions: An
increase in the frequency of equipment breakdowns or calibration failures.
  • Employee Feedback: Reports from staff regarding unclear SOPs or non-compliance with health and safety practices.
  • Likely Causes

    Understanding the origins of compliance issues enables targeted interventions. Causes can be categorized into the following areas:

    Category Potential Causes
    Materials Non-compliant or uncharacterized raw materials leading to quality variances.
    Method Improper analytical or manufacturing methods not adhering to established protocols.
    Machine Faulty machinery causing inconsistent environmental conditions or product formats.
    Man Insufficient training or unclear SOPs resulting in operational errors.
    Measurement Inaccurate measurement tools leading to unreliable data.
    Environment Uncontrolled environmental conditions outside validated ranges impacting product integrity.

    Immediate Containment Actions (first 60 minutes)

    In the event of identifying a potential risk, swift action is critical to contain the situation. Here’s a streamlined approach:

    1. Stop Production: Immediately halt operations if serious compliance concerns arise.
    2. Isolate Affected Areas: Seal off affected areas or equipment to prevent further contamination or risk.
    3. Notify Stakeholders: Alert management and relevant departments (QA, QC, Engineering) of the situation.
    4. Gather Initial Data: Document the circumstances leading to the situation, including timestamps and involved personnel.
    5. Conduct Preliminary Assessments: Verify if any immediate corrective measures can be employed without comprehensive investigation.

    Investigation Workflow

    Once containment measures are enacted, a systematic investigation must follow to ensure thorough analysis and documentation:

    1. Gather Data: Collect all relevant batch records, environmental monitoring data, and incident reports.
    2. Interviews: Conduct interviews with personnel involved to gain insights on the events leading to the issue.
    3. Analyze Trends: Review historical data for similar incidents or patterns and assess QA metrics.
    4. Document Findings: Ensure all findings, discussions, and actions are recorded in compliance with regulations.
    5. Review Protocols: Check Standard Operating Procedures (SOPs) against current practices for relevance and accuracy.

    Root Cause Tools

    Identifying the root cause is sometimes complex but essential. Employ these tools based on the situation:

    5-Why Analysis

    Use the 5-Why technique for straightforward issues where the root cause can be identified quickly. Ask “Why?” up to five times until you reach the fundamental cause.

    Fishbone Diagram

    A Fishbone diagram (Ishikawa) is beneficial for more complicated issues involving multiple potential causes across different categories. This visualization helps categorize concerns and identify areas needing further investigation.

    Fault Tree Analysis (FTA)

    When dealing with complex, critical failures, FTA provides a structured approach to dissect the problem. Use this to identify and quantify the probabilities of various failure pathways.

    CAPA Strategy

    To address the identified root causes effectively, develop a robust Corrective and Preventive Action (CAPA) strategy:

    1. Correction: Implement immediate corrective measures to resolve the issue at hand.
    2. Corrective Action: Identify and implement changes to prevent recurrence of the problem.
    3. Preventive Action: Establish proactive measures to mitigate potential future risks.

    Maintain a closed-loop CAPA process by ensuring every action taken is documented and reviewed for effectiveness in future audits or inspections.

    Related Reads

    Control Strategy & Monitoring

    Craft a comprehensive control strategy to safeguard compliance throughout the pipeline:

    1. Statistical Process Control (SPC): Utilize SPC techniques to monitor processes and detect variances before they lead to non-compliance.
    2. Implement Trending Systems: Analyze trends over time to identify fluctuations in product quality or environmental conditions.
    3. Establish Sampling Schemes: Develop robust sampling methods for ongoing monitoring of critical parameters.
    4. Set Alarms for Critical Deviations: Ensure immediate alerts for conditions that exceed acceptable limits, prompting rapid response.
    5. Verification: Conduct regular audits to validate compliance with both internal and external standards.

    Validation / Re-qualification / Change Control Impact

    Changes in operations or practices can have significant implications for validation and change control processes. Consider the following aspects:

    • Validation Impact: Re-validate processes if substantial changes occur that may affect product quality or compliance.
    • Re-qualification Needed: Adjust protocols if equipment, methods, or materials undergo significant alterations.
    • Change Control Procedures: Initiate change control if new procedures or equipment are implemented to ensure regulatory compliance remains intact.

    Inspection Readiness: What Evidence to Show

    To be inspection-ready, maintain a comprehensive set of documentation:

    • Records: Document all CAPAs, deviations, and subsequent actions meticulously.
    • Logs: Keep equipment and maintenance logs current and detailed to demonstrate compliance.
    • Batch Documents: Ensure batch records reflect all processes accurately, including any issues encountered and resolutions.
    • Deviation Management: Track all deviations in a systematic way to show how issues were addressed.

    FAQs

    What is WHO GMP compliance?

    WHO GMP compliance refers to the standards set by the World Health Organization for ensuring that pharmaceutical products are consistently produced and controlled according to quality standards.

    How can we prepare for a WHO GMP audit?

    Preparation involves conducting thorough internal audits, reviewing quality systems, and ensuring all documentation is complete and up-to-date.

    What documentation is essential during prequalification?

    Essential documentation includes batch records, quality control results, deviation reports, and evidence of training and competency for all personnel.

    How often should validation procedures be reviewed?

    Validation procedures should be assessed regularly and any time there are significant changes to processes, equipment, or regulatory guidance.

    What happens if a deviation is found during an audit?

    If a deviation is found, it should be documented, investigated, and corrective actions should be implemented promptly.

    What are the common causes for inspection failures?

    Common causes include inadequate documentation, non-compliance with SOPs, insufficient training, and poor maintenance of equipment.

    Can we use existing CAPAs for new compliance issues?

    Existing CAPAs can be a valuable reference, but updates may be required to address new issues and ensure relevance to current standards.

    What’s the role of Quality Assurance in compliance activities?

    Quality Assurance oversees compliance activities, ensuring that processes are followed correctly and that the site’s output meets regulatory requirements.

    How can statistical methods help in compliance?

    Statistical methods like SPC help monitor processes in real-time, enabling the identification of trends and deviations before they affect product quality.

    Pharma Tip:  WHO GMP Compliance: A Comprehensive Guide for Pharmaceutical Facilities